Rifamycins – Obstacles and opportunities
Authors:
- George A. GarciaGGGeorge A. Garcia
- 1 March 2010
- journal article
- review article
- Published by Elsevier in Tuberculosis
- Vol. 90 (2) , 94-118
Abstract
No abstract availableKeywords
This publication has 233 references indexed in Scilit:
- Structures of RNA polymerase–antibiotic complexesCurrent Opinion in Structural Biology, 2009
- The RNA Polymerase “Switch Region” Is a Target for InhibitorsCell, 2008
- Rifamycins do not function by allosteric modulation of binding of Mg 2+ to the RNA polymerase active centerProceedings of the National Academy of Sciences, 2008
- Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3European Journal of Pharmacology, 2008
- Rifamycin antibiotic resistance by ADP-ribosylation: Structure and diversity of ArrProceedings of the National Academy of Sciences, 2008
- Rifaximin: A Novel Nonabsorbed Rifamycin for Gastrointestinal DisordersClinical Infectious Diseases, 2006
- Effect of rifampin on CD1b expression and double-negative T cell responses against mycobacteria-dertved glycolipid antigenLife Sciences, 1998
- Rifamycins: an insight into biological activity based on structural investigationsJournal of Molecular Biology, 1974
- A direct effect of some rifamycin derivatives on the morphology of mammalian mitochondriaExperimental Cell Research, 1973
- Antibiotics as Inhibitors of Nucleic Acid and Protein SynthesisAngewandte Chemie International Edition, 1968